Require health insurance plans to cover oral cancer medications at the same cost as intravenous cancer treatments.
One policy goal, tracked across every bill that has carried it.
What’s happening with Cancer Drug Parity Act of 2025?
The Cancer Drug Parity Act of 2025, known as H.R. 4101, has remained in the House Committee on Education and Workforce since June 23, 2025. The committee members must hold a vote to move the bill forward, but most legislation fails to advance past this stage. This effort has seen no recorded action for 12 months, which aligns with the typical pattern for bills that do not receive a committee hearing.
Updated July 9, 2026 · Generated by AI. Always verify with official sources.
Where it stands
Now carried by Cancer Drug Parity Act of 2025 (H.R. 4101 (119th)) →
Legislative Progress
Next up: A house committee · Nothing moves until they act.
How we got here
Every bill that has carried this goal, oldest first.
Died with Congress · Jan 3, 2025
Died when the 118th Congress ended without final passage. Bills must be reintroduced under a new number to be revived.
Reintroduced · Jan 3, 2025
Reintroduced from H.R. 6301 (118th), which died when its Congress ended.
H.R. 6301 (118th) →
Vehicles
Who’s behind it
Glenn Grothman (R-WI)Wrote and sponsored the current bill.